Specific inhibition of allergic reactions to penicillin in man by a monovalent hapten. II. Clinical studies.
D000328:Adult; D000368:Aged; D000485:Allergens; D000906:Antibodies / Q000032:analysis; D001996:Bronchopneumonia / Q000188:drug therapy; D002270:Carbuncle / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002764:Cholecystitis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity / Q000517:prevention & control*; D004698:Endocarditis, Subacute Bacterial / Q000188:drug therapy; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy; D006241:Haptens; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007669:Kidney Calculi / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010400:Penicillin G / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects*; D011552:Pseudomonas Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D012882:Skin Tests; D013203:Staphylococcal Infections / Q000188:drug therapy
D000485:Allergens; D000906:Antibodies; D006241:Haptens; D010406:Penicillins; D010400:Penicillin G